| __timestamp | Halozyme Therapeutics, Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 52602000 | 25469000000 |
| Thursday, January 1, 2015 | 105812000 | 24564000000 |
| Friday, January 1, 2016 | 113485000 | 25916000000 |
| Sunday, January 1, 2017 | 285461000 | 27347000000 |
| Monday, January 1, 2018 | 141726000 | 28785000000 |
| Tuesday, January 1, 2019 | 150446000 | 32728000000 |
| Wednesday, January 1, 2020 | 224227000 | 27900000000 |
| Friday, January 1, 2021 | 361897000 | 35078000000 |
| Saturday, January 1, 2022 | 520812000 | 41872000000 |
| Sunday, January 1, 2023 | 636892000 | 43989000000 |
Igniting the spark of knowledge
In the ever-evolving landscape of the pharmaceutical industry, the financial health of companies is a key indicator of their market position and potential for innovation. Over the past decade, Merck & Co., Inc. and Halozyme Therapeutics, Inc. have showcased contrasting trajectories in their gross profit trends. From 2014 to 2023, Merck's gross profit has consistently dwarfed that of Halozyme, with Merck's figures peaking at nearly 44 billion in 2023, a staggering 69 times higher than Halozyme's 637 million. However, Halozyme's growth rate is noteworthy, with a 1,110% increase over the same period, compared to Merck's 73% rise. This stark contrast highlights the different scales and growth strategies of these two industry players, offering insights into their operational efficiencies and market strategies.
Gross Profit Analysis: Comparing Merck & Co., Inc. and Sanofi
Gross Profit Trends Compared: Merck & Co., Inc. vs Teva Pharmaceutical Industries Limited
Merck & Co., Inc. vs BioMarin Pharmaceutical Inc.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Merck & Co., Inc. vs Walgreens Boots Alliance, Inc.
Gross Profit Comparison: Merck & Co., Inc. and Catalent, Inc. Trends
Merck & Co., Inc. vs Grifols, S.A.: A Gross Profit Performance Breakdown
Key Insights on Gross Profit: Merck & Co., Inc. vs Alkermes plc
Merck & Co., Inc. and Travere Therapeutics, Inc.: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Amgen Inc. vs Halozyme Therapeutics, Inc.
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Perrigo Company plc Trends
Gross Profit Comparison: Halozyme Therapeutics, Inc. and Evotec SE Trends
Halozyme Therapeutics, Inc. and MiMedx Group, Inc.: A Detailed Gross Profit Analysis